Beijing, China

Zhongxiong Tang



Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Zhongxiong Tang

Introduction

Zhongxiong Tang is a notable inventor based in Beijing, China, recognized for his advancements in the field of pharmaceutical innovations. With a total of three patents to his name, Tang has made significant contributions to the development of therapeutic solutions, particularly in anticoagulant and diabetes treatment.

Latest Patents

Zhongxiong Tang's latest inventions include two pivotal patents. The first patent, titled "Preparation of low bleeding anticoagulant fusion protein and its use," details an anticoagulant fusion protein that contains oligopeptides recognizable and cleavable by factor XIa or thrombin and factor Xa. This invention outlines both the preparation method and the medicinal applications of the protein, emphasizing its potential in improving patient outcomes in anticoagulation therapy.

The second patent, "Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes," focuses on specific chemical compounds that can be utilized in drug development. This patent addresses cis-1,2-substituted stilbene derivatives, along with their pharmaceutically acceptable salts and formulations, proposing their use in the treatment and prevention of diabetes and related complications.

Career Highlights

Zhongxiong Tang has had a distinguished career, working with prominent institutions such as the Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA, and Beijing Luyin Lihua Pharmaceutical Science and Technology Development Company Ltd. His experience in these organizations has been instrumental in his research and development efforts, leading to groundbreaking innovations in healthcare.

Collaborations

Throughout his career, Tang has collaborated with esteemed colleagues, including Zuze Wu and Junlin Li. Their combined expertise has fostered a rich environment for research and innovation, allowing for the successful development of several therapeutic solutions.

Conclusion

Zhongxiong Tang exemplifies the spirit of innovation within the pharmaceutical industry. His work not only contributes to the field of medicine but also addresses pressing health issues such as anticoagulation and diabetes management. As he continues to pursue research and development, Tang’s future inventions hold promise for improving healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…